| 000 | 01336 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512040343.0 | ||
| 264 | 0 | _c19880805 | |
| 008 | 198808s 0 0 eng d | ||
| 022 | _a0277-5379 | ||
| 024 | 7 |
_a10.1016/0277-5379(88)90299-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChisesi, T | |
| 245 | 0 | 0 |
_aA phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer & clinical oncology _cApr 1988 |
||
| 300 |
_a681-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aDaunorubicin _xadverse effects |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIdarubicin |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 700 | 1 | _aCapnist, G | |
| 700 | 1 | _ade Dominicis, E | |
| 700 | 1 | _aDini, E | |
| 773 | 0 |
_tEuropean journal of cancer & clinical oncology _gvol. 24 _gno. 4 _gp. 681-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0277-5379(88)90299-4 _zAvailable from publisher's website |
| 999 |
_c3170058 _d3170058 |
||